About Me
-
Phone:
0000-0000000 -
Email:
[email protected] -
Experience:
14+ Years -
Resume: Download
Dr. Mohammed Nasir Riaz is a distinguished academic and researcher with expertise in the molecular biology of viral infections and diagnostics. Since January 2012, he has been serving as a Lecturer in the Department of Microbiology. Dr. Nasir earned his Ph.D. in 2021 at the Kirby Institute, UNSW, Sydney, as part of the Viral Immunology Systems Project, funded by the Australian Government (NHMRC Australia and UNSW). His doctoral research focused on whole-genome sequencing of RNA viruses to explore within-host viral evolution, characterize viral variants at the quasi-species level, analyze antiviral drug resistance, and investigate virus-host immune interactions for effective vaccine development. His notable contributions include the development of rapid, highly sensitive, and cost-effective methodologies for sequencing entire genomes of Dengue and HCV, later adapted for sequencing COVID-19 genomes during the pandemic. Dr. Nasir’s academic career is underscored by his significant contributions during his M.Phil. in Virology and Immunology, where he participated in national and international projects on the molecular virology and epidemiology of Dengue and Hepatitis (HCV, HBV, and HDV). Prior to his academic appointment, he served as a Research Officer at a Molecular Diagnostics Laboratory from 2009 to 2011, where he played a crucial role in establishing the lab and optimizing molecular diagnostic tests. His outstanding contributions to virology and molecular diagnostics have earned him several prestigious accolades, including: The Australian Commonwealth University International Postgraduate Award, collectively valued at over $300,000. The School of Medical Sciences Ph.D. Award from UNSW. The Young Scientist of the Year 2019 in Molecular Diagnostics Award from the Australian Centre for HIV and Hepatitis Virology Research (ACH2). Following the successful completion of his Ph.D., Dr. Nasir resumed his academic role at HU in 2022. He remains committed to advancing the field of molecular diagnostics and virology through innovative research. His work continues to shape the development of diagnostic tools and effective vaccine strategies against life-threatening viruses worldwide.